Offerings - Offering: 1 |
Oct. 06, 2026
USD ($)
shares
|
|---|---|
| Offering: | |
| Fee Previously Paid | false |
| Other Rule | true |
| Security Type | Equity |
| Security Class Title | Common Stock, par value $0.0001 per share |
| Amount Registered | shares | 2,368,868 |
| Proposed Maximum Offering Price per Unit | 1.605 |
| Maximum Aggregate Offering Price | $ 3,802,033.14 |
| Fee Rate | 0.0087% |
| Amount of Registration Fee | $ 330.78 |
| Offering Note | (1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover an indeterminate number of additional shares of common stock, par value $0.0001 per share (Common Stock"), of Decoy Therapeutics Inc. (the "Registrant") as may be issued or issuable resulting from stock splits, stock dividends or similar transactions. (2) Consists of up to 2,368,868 shares of Common Stock issuable upon exercise of warrants issued in a private placement that closed on September 23, 2026. The Registrant will not receive any proceeds from the resale of such shares by the selling stockholder. (3) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) of the Securities Act, based on the average of the high and low prices for a share of the Registrant's Common Stock as reported on the Nasdaq Stock Market, LLC on October 6, 2026, which is a date within five business days of the filing of the Registration Statement. |